What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?

The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.

Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.

Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.

What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles?

How can data-driven service design improve patient support programs and outcomes?

How are payers thinking about apps, wearables and other digital health technologies?